Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.
Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.
FYN is overexpressed in human prostate cancer.
Stamp out lung cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FYN is overexpressed in human prostate cancer.
FYN is overexpressed in human prostate cancer. BJU Int. 2009 Jan; 103(2):171-7.
View in:
PubMed
subject areas
Adult
Aged
Blotting, Western
Case-Control Studies
Focal Adhesion Kinase 1
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Male
Middle Aged
Paxillin
Prostatic Intraepithelial Neoplasia
Prostatic Neoplasms
Proto-Oncogene Proteins c-fyn
Reverse Transcriptase Polymerase Chain Reaction
Up-Regulation
authors with profiles
Carrie Rinker-Schaeffer
Ravi Salgia
Ramasamy Jagadeeswaran